These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20039399)

  • 21. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
    Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
    Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
    J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
    Qu SJ; Ye H; Jia RL; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of HLA-DRB alleles on the subclass titres of antibodies against citrullinated peptides.
    Engelmann R; Eggert M; Neeck G; Mueller-Hilke B
    Rheumatology (Oxford); 2010 Oct; 49(10):1862-6. PubMed ID: 20584722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
    Al-Jarallah K; Shehab D; Al-Attiyah R; Al-Azmi W; Al-Fadli A; Zafar Haider M; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2012 Sep; 18(9):1655-62. PubMed ID: 22114016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.
    Poulsom H; Charles PJ
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):4-10. PubMed ID: 18270850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
    Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
    Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.
    van der Woude D; Scherer HU; Huizinga TW; Toes RE
    Arthritis Rheum; 2013 Feb; 65(2):541-2. PubMed ID: 23055177
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
    Besada E; Nikolaisen C; Nossent H
    Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply: Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.
    Montes A; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2013 Feb; 65(2):542. PubMed ID: 23055154
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
    Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
    J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intriguing relationship between the immune response to citrullinated vimentin and the HLA shared epitope: comment on the article by Verpoort et al.
    Bell DA; Hill JA; Cairns E
    Arthritis Rheum; 2008 Oct; 58(10):3277; author reply 3277-8. PubMed ID: 18821677
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.
    Wagner E; Skoumal M; Bayer PM; Klaushofer K
    Rheumatol Int; 2009 Sep; 29(11):1315-21. PubMed ID: 19184032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
    Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
    Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
    Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
    Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
    Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis.
    Varadé J; Loza-Santamaría E; Fernández-Arquero M; Lamas JR; de Los Angeles Figueredo M; Jover JA; de la Concha EG; Rodríguez L; Urcelay E; Fernández-Gutiérrez B; Martínez-Doncel A
    J Rheumatol; 2009 May; 36(5):1085-6. PubMed ID: 19435975
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al.
    Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
    Arthritis Rheum; 2006 Aug; 55(4):681-2; author reply 682. PubMed ID: 16874773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.